MedPath

Somatropin effects on liver fat content in AGHD patients-a single centre non-interventional study

Not Applicable
Conditions
Adult growth hormone deficiency
Registration Number
JPRN-UMIN000044989
Lead Sponsor
Department of Endocrinology, Metabolism & Diabetes, Kitasato University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1, Patients before and after surgery or with severe trauma 2, Patients with excessive alcohol intake. Estimated ethanol equivalent based on the patient's self-report; 30 g/day for men, 20g /day or more for women 3, Patients with undeniable complications of other liver diseases, including viral hepatitis, autoimmune hepatitis, and drug-induced hepatitis. 4, Patients with severe hepatic impairment, cirrhosis of the liver of Child-Pugh classification B or C 5, Patients with hepatitis virus infection 6, Patients with an apparent malignant tumor 7, Women who are pregnant or may become pregnant 8, Under 20 years old and over 80 years old 9, Patients with mental retardation or linguistic problems that prevent them from fully understanding the research content

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath